Login / Signup

The Association of Thyroid-Stimulating Hormone (TSH) Levels and Lipid Profile in Euthyroid Patients with Familial Hypercholesterolemia.

Maryam HeidarpourParastesh RezvanianMohammad Amin SadriParsa KeshavarzradRezvan ZakeriOmid VakilbashiDavood ShafieMasood ShekarchizadehSonia ZarfeshaniNajmeh RabbanipourJamshid NajafianGolnaz VaseghiNizal Sarrafzadegan
Published in: BioMed research international (2023)
Previous studies reported a relationship between thyroid-stimulating hormone (TSH) and low-density lipoprotein cholesterol (LDL-C) levels. In this study, we aim to evaluate the impact of TSH levels on lipid profile in patients with familial hypercholesterolemia (FH) and euthyroid state. Patients were selected from the Isfahan FH registry. The Dutch Lipid Clinic Network (DLCN) criteria are used to detect FH. Patients were classified into no FH, possible FH, probable FH, and definite FH groups based on the DLCN scores. Patients with any cause of secondary hyperlipidemia, including hypothyroidism, were excluded from this study. The study group consisted of 103 patients with possible FH, 25 patients with definite FH, and 63 individuals with no FH. The mean TSH and LDL-C levels among participants were 2.10 ± 1.22 mU/l and 142.17 ± 62.56 mg/dl, respectively. No positive or negative correlation was found between serum TSH and total cholesterol ( P value = 0.438), high-density lipoprotein cholesterol ( P = 0.225), triglycerides ( P value = 0.863), and LDL-C ( P value = 0.203). We found no correlation between serum TSH levels and lipid profiles in euthyroid patients with FH.
Keyphrases
  • end stage renal disease
  • ejection fraction
  • newly diagnosed
  • chronic kidney disease
  • prognostic factors
  • adipose tissue
  • skeletal muscle
  • metabolic syndrome
  • fatty acid
  • insulin resistance
  • patient reported outcomes